Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by forhandlarenon Jun 30, 2021 5:49pm
180 Views
Post# 33477550

Not happy, but ready to reap the fruit

Not happy, but ready to reap the fruitDo I feel mislead over the years? Yes - after the departure of Neil
Do I appreciate bonuses that drain the company? No
Is the science solid? Yes

Do I trust the management to close profitable deals? No, but deals cannot be avoided due to the solid science. Hopefully, there's competition between parties to actually turn it into decent deals.

If I was fresh to the table I'd probably consider todays share price a great entry point. There's a lot of disappointed investors around that holds the share price back - for good reasons, but the company might be on the verge to finally break through.

The upcoming July Investor Presentation will be very interesting in light of todays update, especially if they keep the milestones planning.
<< Previous
Bullboard Posts
Next >>